<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Katic, Alain</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">A Review of Recent Studies of Lisdexamfetamine Dimesylate for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-20</style></pages><abstract><style  face="normal" font="default" size="100%">The impact of attention deficit hyperactivity disorder (ADHD) extends beyond the symptoms of hyperactivity and inattentiveness. Approximately one-quarter of children with ADHD are reported as having emotional problems, expressed as temper outbursts, mood lability, and dysphoria [American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 2000], all of which impair the quality of life of the child and his family [Escobar R et al. Pediatrics 2005; Klassen AF, Miller A, Fine S. Pediatrics 2004].</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>